1. The neuroleptic [ 3H]-haloperidol (HP) was taken up in synaptosomes prepared from rat brain, in a temperature-, sodium ion-, and energy-dependent process. 2. The highest concentration of uptake sites (V max=2.37 pmol mg -1 protein min -1) was in the striatum with the other brain areas displaying lower (by 50-70%) values. 3. The affinity values (K m≈40 nM) were similar in all brain areas considered. 4. The pharmacological characterization did not indicate a well-defined group of inhibitors, which suggested that HP might not use a transporter for recognized neurotransmitters. 5. The HP metabolites tested, including HPTP, were competitive inhibitors of [ 3H]-HP uptake, an indirect indication that they may actively enter the striatal nerve endings through the same carrier. 6. Since the uptake process was partially affected by the incubation of [ 3H]-HP in the presence of several antagonists of HP-transforming cytochrome P450 isoforms, the binding of HP at some enzyme sites inside the synaptosome cannot be excluded. 7. In conclusion, the present results suggest that HP may be actively transported in the rat brain.

In vitro evidence for the presence of [ 3H]-haloperidol uptake in rat brain / Ruiu, S.; Marchese, G.; Saba, P. L.; Satta, R.; Gessa, G.; Vaccari, A.; Pani, L.. - In: BRITISH JOURNAL OF PHARMACOLOGY. - ISSN 0007-1188. - 138:1(2003), pp. 188-192. [10.1038/sj.bjp.0705009]

In vitro evidence for the presence of [ 3H]-haloperidol uptake in rat brain

Pani L.
2003

Abstract

1. The neuroleptic [ 3H]-haloperidol (HP) was taken up in synaptosomes prepared from rat brain, in a temperature-, sodium ion-, and energy-dependent process. 2. The highest concentration of uptake sites (V max=2.37 pmol mg -1 protein min -1) was in the striatum with the other brain areas displaying lower (by 50-70%) values. 3. The affinity values (K m≈40 nM) were similar in all brain areas considered. 4. The pharmacological characterization did not indicate a well-defined group of inhibitors, which suggested that HP might not use a transporter for recognized neurotransmitters. 5. The HP metabolites tested, including HPTP, were competitive inhibitors of [ 3H]-HP uptake, an indirect indication that they may actively enter the striatal nerve endings through the same carrier. 6. Since the uptake process was partially affected by the incubation of [ 3H]-HP in the presence of several antagonists of HP-transforming cytochrome P450 isoforms, the binding of HP at some enzyme sites inside the synaptosome cannot be excluded. 7. In conclusion, the present results suggest that HP may be actively transported in the rat brain.
138
1
188
192
In vitro evidence for the presence of [ 3H]-haloperidol uptake in rat brain / Ruiu, S.; Marchese, G.; Saba, P. L.; Satta, R.; Gessa, G.; Vaccari, A.; Pani, L.. - In: BRITISH JOURNAL OF PHARMACOLOGY. - ISSN 0007-1188. - 138:1(2003), pp. 188-192. [10.1038/sj.bjp.0705009]
Ruiu, S.; Marchese, G.; Saba, P. L.; Satta, R.; Gessa, G.; Vaccari, A.; Pani, L.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11380/1212118
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 3
  • ???jsp.display-item.citation.isi??? 3
social impact